Attention Deficit Hyperactivity Disorder (ADHD) is one of the most commonly diagnosed disorder in children .it may result to symptoms from mild to severe depending on the individual, some of the symptoms are lack of sleep, lack of attention, poor focus, uncontrollable impulses, low self-esteem and other related symptoms. Relationships and career choices are at stake if ADHD progress to adulthood especially if left untreated. Read more about Neurocore at muscletech.com.
Neurocore Brain Performance Centres have been committed and reliable in providing aid to many characterized by ADHD, anxiety, and depression. Neurocore got established in 2004 by Dr. Tim Royer who previously worked at Helen DeVos Children’s Hospital as a neuropsychologist.
In Grandville, Neurocore clinic’s therapy area patients are filled having electrodes on their heads and ears to graph their brain, heart and breathing waves as they watch a movie.
According to Rochelle Fintelman Neurocore clinical specialist, the clinic uses neurofeedback and a brain teaching program with a biofeedback mix as therapy. Which is teaching technology charting patients’ brain activity and how to breathe deeply respectively. A patient’s movie plays uninterrupted when their brain activity is balanced and calm and pauses or shrinks if imbalanced, with time the brain recognizes the pauses and rectifies the brain’s wave.
Neurofeedback has been praised by many for being a useful technique for overcoming depression, stress, and ADHD. As a result focus and attention improves while eliminating other undesirable symptoms like stress. Worth acknowledging is that this technique does not require drugs.
Rising concern was the use of Ten20 paste which is a topically applied cream used to prep the head and earlobes to facilitate placement of the electrode. The cream was critiqued to be carcinogenic. However, remarks of Nick Bolhuis Director of Clinical Operations at Neurocore clarified the concern and confirmed that it was not carcinogenic. By stating that various medical institutions used ten20 cream and the reported side effect was slight skin irritation or drying for those with sensitive skin. He also said that an alternate paste could be offered in such a situation though it rarely occurs.
Neurocore has transformed the lives of many both young and adults and deserves a chance to make a lasting impact. Follow Neurocore on twitter.com.
The technology advancement in the healthcare sector has made some significant changes in the way how the treatment is being provided. In the recent years, preventive healthcare has got greater attention due to accurate, scientific, and efficient screening and medication using the advancement of technology innovation. This is what Life Line Screening, a prominent preventive healthcare and screening provider in the United States, is efficiently utilizing the advanced screening and medication options. Recently, the company announced its plans to come up with most-modern bone density screening choices for the people of America by collaborating with Bone Index, Ltd – a leader in medical devices making.
Life Line Screening identified that undiagnosed osteoporosis is a major healthcare challenge across the world. While coming to the United States, it causes nearly two million broken bones per year that costs more than $19 billion in healthcare expenses. A forecast done by medical experts points out that it would bet $25.3 billion by 2025. The biggest challenge in the area is limited early diagnosis options as bone density scans are generally performed in hospitals equipped with DXA X-ray machines, which is highly expensive for the people.
Dr. OssiRiekkinen, the Chief Executive of Bone Index, confirms that this is where Bindex® becomes a real game changer in osteoporosis treatment delivery. He added that Life Line Screening is a leader in wellness and health services in the country with over 15,000 screening events, and that includes ultrasound screening for bone density and vascular disease. The VP of Business Development at Life Line Screening, Kelly Daubach, says that its collaboration with Bone Index helps the wellness screening provider to facilitate convenient and more accurate bone density screening for the people. He also claimed that no other healthcare screening provider could offer safer, accurate, and simplified tests for osteoporosis.
Interestingly, Bindex® is a point-of-care device that screens the cortical bone density of the tibia. Later, the algorithm set in the system calculates the Bone Density Index, which is a parameter in deciding the bone mineral density at the butt measured with DXA. Additionally, Bindex® is a system that holds 19 patents in countries around the world including Japan, China, the United States, and many European countries. Dr. Riekkinen confirmed that Bindex is a widely accepted system across the globe, and it was used in the osteoporosis screening campaign conducted in Finland – the biggest campaign in the world. He continued that Bindex is happy to join hands with Life Line to improve the quality life of Americans.
Visit More : www.lifelinescreeningwellness.com/
An estimated one in every seven men in the world has prostate cancer. There will be roughly 16360 new diagnoses of cancer in 2017 according to American research institute. People who are 40 years old are most affected prostate cancer. To increase awareness in early screening of prostate cancer LabCorp, National Football League and Cancer Treatment Organization of America have collaborated inorder to beef up their efforts.
Several head coaches among them Herm Edwards, Dick Vermeil and Bill Cowher, will spearhead the prostrate pep talk. The talk aims to raise awareness and encourage men to get screening services. There will be press briefing and meetings to be held on late August, New Jersey .Edward a recipient of numerous Emmy awards will host the event and Beasley Reece will be the keynote speaker. The rest of the campaigns will take place in Atlanta, Chicago, Phoenix, and Tulsa.
NFL and LabCorp have stressed on the importance on being screened for prostate cancer. The screening is then followed up by diagnosis and various treatment methods. PSA tests don’t necessarily give a clear indication of the stage of cancer the type of treatment one should receive. If the screening indicates high levels of PSA, it shows that ne is at a high risk of prostate cancer and it’s advisable to discuss the methods of treatment with a doctor. LabCorp and NFLA are providing free and cheaper PSA screening. Men with PSA levels falling over the range outside normal are advised to seek the services of physicians immediately. PSA tests are conducted by LabCorp, at their centers countrywide.
The NFLA provides funding medicine and other development programs to help members’ live healthy and productive lives. The association consists of coaches, staffers, cheerleaders and associate members.
The cancer treatment Centre of America global, Inc. (CTCA) is a chain of five hospitals offering medical care to adult patients with cancer. CTCA combines advanced genomic testing, cancer treatment and chemotherapy which is more thorough. The treatment is designed to help patients physically and emotionally. CTCA is ranked high among the hospitals providing cancer treatment. The patients who go into the hospitals have given positive feedback regarding the services offered.
LabCorp is a science company that is involved in guiding patients, giving thorough clinical laboratory and drug development services. LabCorp provides delivery services for its drugs faster with the use of modern technology.
Visit More : http://www.myctca.com
Fans of the Fox News Channel show “Sunday House Call” will be thrilled to learn that Dr. Samadi is now hosting his own show. The name of the show is Sunday Housecall with Dr. Samadi. He will undoubtedly gain legions of new fans with this new weekly broadcast. The presentation is live and the format will be discussions with with medical experts about physical and mental health issues.
Topical and important health issues will be covered of course as well as exercise, diet, mental health and general wellness. Dr. Samadi will host a diversified group of guests with knowledge in all of these fields and more. He will take calls live from viewers, and will be answering questions written in and emailed by viewers. Dr. David B. Samadi has been a contributor to Fox News as a health expert since 2009. He was a Team Anchor on “Sunday House Call” during its five and a half year run.
The new show can be seen online at Facebook, Twitter, and at Dr.SamadiTV.com. It will air every Sunday at 12:30pm Eastern Time. It will no doubt be informative and exciting.
At Lenox Hill Hospital in New York City Dr. Samadi currently serves as Chairman of Urology, also Chief of Robotic Surgery. His background is impressive and fascinating. In 1979 he fled Iran, along with his brother, to Belgium and London and then to the United States. He earned his Bachelor’s degree at Stony Brook University and then went on to Stony Brook School of Medicine, earning an M.D. in 1994. He continued his post graduate work at Montefiore Medical Center, trained in proctology at Albert Einstein College of Medicine and gained a Fellowship in Proctology at Memorial Sloan Kettering Cancer Center in 2001. Then he heard about work being done at Henri Mondor Hospital Creteil in France in the field of prostate surgery. He earned a Fellowship to mentor there under Professor Claude Abbou in 2002.
Dr. Samadi owns a patent for a robotic surgery entitled SMART. That stands for Samadi Modified Advanced Robotic Technique. It is a surgery that preserves the nerves surrounding the prostate during robotic prostate surgery.
Obviously, Dr. Samadi’s main interest is in men’s health. He considers it his mission to educate and help people in this field. His show, “Sunday Housecall with Dr. Samadi” will also examine women’s health issues and every day habits and ways to stay well.
Read More: prostatecancer911.com/david-samadi/